ADRAC ceases after nearly 40 years

The Australian Adverse Drug Reactions Committee (ADRAC) will cease to exist at the end of this year, after nearly 40 years advising the therapeutic goods administration (TGA) on the safety of medicines. ADRAC will be replaced next year by a new expert advisory committee established under the Therapeutic Goods Act. “The Advisory Committee on the Safety of Medicines (ACSOM) will encompass the activities and functions of ADRAC but will have broader terms of reference commensurate with the increasing prominence of pharmacovigilance in Australia and world-wide,” ADRAC said in its final bulletin....